The data thus far is impressive. Hopefully the next trial will follow suit and build on the momentum from the higher dose as it reaches PR quite swiftly >30% relief in tumor burden. Optimistic they have something special here. Time will tell and think also the US trial will really be a massive value creator with their different SOC. Other targets as well!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.020(10.8%) |
Mkt cap ! $99.72M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.5¢ | 19.0¢ | $998.1K | 5.012M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10390 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 199189 | 6 |
View Market Depth
| Last trade - 16.20pm 08/08/2025 (20 minute delay) ? |
| ATX (ASX) Chart |